Blanchard AC, Waters VJ (2019) Microbiology of cystic fibrosis airway disease. Semin Respir Crit Care Med 40:727–736. https://doi.org/10.1055/s-0039-1698464

Article  PubMed  PubMed Central  Google Scholar 

Jurado-Martín I, Sainz-Mejías M, McClean S (2021) Pseudomonas aeruginosa: an audacious pathogen with an adaptable arsenal of virulence factors. Int J Mol Sci 22:1–37

Article  Google Scholar 

Govan JR, Deretic V (1996) Microbial pathogenesis in cystic fibrosis: mucoid Pseudomonas aeruginosa and Burkholderia cepacia. Microbiol Rev 60:539–574. https://doi.org/10.1111/j.1365-2672.2007.03706.x

Article  CAS  PubMed  PubMed Central  Google Scholar 

Pritt B, O’Brien L, Winn W (2007) Mucoid Pseudomonas in cystic fibrosis. Am J Clin Pathol 128:32–34. https://doi.org/10.1309/KJRPC7DD5TR9NTDM

Article  PubMed  Google Scholar 

Li Z, Kosorok MR, Farrell PM et al (2005) Longitudinal development of mucoid Pseudomonas aeruginosa infection and lung disease progression in children with cystic fibrosis. JAMA 293:581–588

Article  CAS  PubMed  Google Scholar 

Talwalkar JS, Murray TS (2016) The Approach to Pseudomonas aeruginosa in Cystic Fibrosis. Clin Chest Med 37:69–81. https://doi.org/10.1016/j.ccm.2015.10.004

Article  PubMed  Google Scholar 

Clark ST, Diaz Caballero J, Cheang M et al (2015) Phenotypic diversity within a Pseudomonas aeruginosa population infecting an adult with cystic fibrosis. Sci Rep 5:10932. https://doi.org/10.1038/srep10932

Article  CAS  PubMed  PubMed Central  Google Scholar 

Høiby N, Ciofu O, Bjarnsholt T (2010) Pseudomonas aeruginosa biofilms in cystic fibrosis. Future Microbiol 5:1663–1674. https://doi.org/10.2217/fmb.10.125

Article  PubMed  Google Scholar 

Tai AS, Sherrard LJ, Kidd TJ et al (2017) Antibiotic perturbation of mixed-strain Pseudomonas aeruginosa infection in patients with cystic fibrosis. BMC Pulm Med 17:1–10. https://doi.org/10.1186/s12890-017-0482-7

Article  CAS  Google Scholar 

Malhotra S, Hayes D, Wozniak DJ (2019) Mucoid Pseudomonas aeruginosa and regional inflammation in the cystic fibrosis lung. J Cyst Fibros 18:796–803. https://doi.org/10.1016/j.jcf.2019.04.009

Article  CAS  PubMed  PubMed Central  Google Scholar 

Malhotra S, Limoli DH, English AE et al (2018) Mixed communities of mucoid and nonmucoid pseudomonas aeruginosa exhibit enhanced resistance to host antimicrobials. mBio. 9:1–15. https://doi.org/10.1128/mBio

Article  Google Scholar 

Goddard M (2011) Histopathology of bronchiectasis. Bronchiectasis. https://doi.org/10.1183/1025448x.10003310

Article  Google Scholar 

Dasenbrook EC, Lu L, Donnola S et al (2013) Normalized T1 magnetic resonance imaging for assessment of regional lung function in adult cystic fibrosis patients—a cross-sectional study. PLoS ONE 8:1–7. https://doi.org/10.1371/journal.pone.0073286

Article  CAS  Google Scholar 

Li Z, Sanders DB, Rock MJ et al (2012) Regional differences in the evolution of lung disease in children with cystic fibrosis. Pediatr Pulmonol 47:635–640. https://doi.org/10.1002/ppul.21604

Article  PubMed  Google Scholar 

Wyckoff TJO, Thomas B, Hassett DJ, Wozniak DJ (2002) Static growth of mucoid Pseudomonas aeruginosa selects for non-mucoid variants that have acquired flagellum-dependent motility. Microbiology (N Y) 148:3423–3430. https://doi.org/10.1099/00221287-148-11-3423

Article  CAS  Google Scholar 

Ciofu O, Lee B, Johannesson M et al (2008) Investigation of the algT operon sequence in mucoid and non-mucoid Pseudomonas aeruginosa isolates from 115 Scandinavian patients with cystic fibrosis and in 88 in vitro non-mucoid revertants. Microbiology (N Y) 154:103–113. https://doi.org/10.1099/mic.0.2007/010421-0

Article  CAS  Google Scholar 

Govan JRW, Fyfe JAM, McMillan C (1979) The instability of mucoid pseudomonas aeruginosa: fluctuation test and improved stability of the mucoid form in shaken culture. J Gen Microbiol 110:229–232

Article  CAS  PubMed  Google Scholar 

Dubin PJ, Kolls JK (2007) IL-23 mediates inflammatory responses to mucoid Pseudomonas aeruginosa lung infection in mice. Am J Physiol Lung Cell Mol Physiol 292:L519–L528. https://doi.org/10.1152/ajplung.00312.2006

Article  CAS  PubMed  Google Scholar 

Ribeiro CMP, Higgs MG, Muhlebach MS et al (2023) Revisiting host-pathogen interactions in cystic fibrosis lungs in the era of CFTR modulators. Int J Mol Sci 24(5):5010

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gifford AH, Matsuoka M, Ghoda LY et al (2012) Chronic inflammation and lung fibrosis: pleotropic syndromes but limited distinct phenotypes. Mucosal Immunol 5:480–484

Article  CAS  PubMed  Google Scholar 

Lammertyn EJ, Vandermeulen E, Bellon H et al (2017) End-stage cystic fibrosis lung disease is characterised by a diverse inflammatory pattern: an immunohistochemical analysis. Respir Res 18:1–9. https://doi.org/10.1186/s12931-016-0489-2

Article  CAS  Google Scholar 

Sajjan U, Corey à M, Humar]}}});">Buy article PDF 39,95 €